Humanized anti-ccr2 antibodies and methods of use therefor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01)

Patent

CA 2529694

The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.

L'invention concerne un anticorps humanisé, ou un fragment fonctionnel de celui-ci, se liant à un mammifère (par exemple, humain), du type comprenant un récepteur de chimiokine-CC (CCR2) ou une portion du récepteur, et des liaisons de séquences d'un ligand au récepteur. L'invention concerne en outre un procédé d'inhibition de l'interaction d'une cellule porteuse de CCR2 mammifère avec un ligand de celui-ci, ainsi que l'utilisation des anticorps et fragments de ceux-ci dans des procédés thérapeutiques, prophylactiques et de diagnostic.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Humanized anti-ccr2 antibodies and methods of use therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Humanized anti-ccr2 antibodies and methods of use therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized anti-ccr2 antibodies and methods of use therefor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1675572

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.